Monday, June 29, 2020

Sun Pharma gets nod from Japan govt for plaque psoriasis treatment drug

Sun Pharma gets nod from Japan govt for plaque psoriasis treatment drug The wholly-owned subsidiary has received approval from Japan#39;s Ministry of Health, Labour and Welfare for Ilumya (tildrakizumab) for the treatment of plaque psoriasis in adult patients who have an inadequate response to conventional therapies, Sun Pharmaceutical Industries said in filing to BSE.

from Moneycontrol Business News https://ift.tt/3dJWFPB
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

S&P 500, Nasdaq end higher on Amazon-OpenAI deal; Fed path forward grows murky

Artificial intelligence deals propelled the S&P 500 and Nasdaq higher on Monday, with Amazon's $38 billion agreement with OpenAI and...